The erasme study: A multicenter study on the safety and technical results of the palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis

Abstract

Renal artery stenting has a high technical success rate, a complication rate comparable to percutaneous transluminal renal angioplasty, and a low rate of restenosis at 8 months angiographic follow-up.

Treatment of renovascular hypertension by transluminal angioplasty – 13 years experience in a single centre

“…The frequency of 10% is within that reported in other studies (28,29), and did not include loss of renal function by the procedure.…”

Predicting blood pressure response after renal artery stenting

“…1 Despite high technical success and relatively low complication rates, sustained blood pressure control and improved renal function have not been uniformly achieved. [2][3][4][5][6][7] However, previous studies suggest that some patients respond well to renal artery stent (RAS) placement, at least in the short-term, whereas others do not. [6][7][8][9][10][11] The group of patients that will benefit most from therapy has not been identified.…”

Percutaneous transluminal renal angioplasty in atheroma with renal failure: long-term outcomes in 99 patients

“…Indeed, adaptation of the kidney to ischemia results in pathological changes that are reversible at first, then irreversible [25]. After PTRA, the sudden pressure increase within the microcirculation of nephrons at the 2528 However, primary ostial stenting which is presently considered as state of the art in the case of ostial lesions [26,27] has not been performed systematically in our population. Besides, Doppler examination could be available only for one-third of patients.…”